These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 18620706)

  • 1. Blockade of NF-kappaB using IkappaB alpha dominant-negative mice ameliorates cardiac hypertrophy in myotrophin-overexpressed transgenic mice.
    Young D; Popovic ZB; Jones WK; Gupta S
    J Mol Biol; 2008 Sep; 381(3):559-68. PubMed ID: 18620706
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of nuclear factor κB regresses cardiac hypertrophy by modulating the expression of extracellular matrix and adhesion molecules.
    Kumar S; Seqqat R; Chigurupati S; Kumar R; Baker KM; Young D; Sen S; Gupta S
    Free Radic Biol Med; 2011 Jan; 50(1):206-15. PubMed ID: 21047552
    [TBL] [Abstract][Full Text] [Related]  

  • 3. NF-kappaB activation is required for adaptive cardiac hypertrophy.
    Zelarayan L; Renger A; Noack C; Zafiriou MP; Gehrke C; van der Nagel R; Dietz R; de Windt L; Bergmann MW
    Cardiovasc Res; 2009 Dec; 84(3):416-24. PubMed ID: 19620128
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of p53 in the transition of myotrophin-induced cardiac hypertrophy to heart failure.
    Das B; Young D; Vasanji A; Gupta S; Sarkar S; Sen S
    Cardiovasc Res; 2010 Aug; 87(3):524-34. PubMed ID: 20202977
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevention of cardiac hypertrophy and heart failure by silencing of NF-kappaB.
    Gupta S; Young D; Maitra RK; Gupta A; Popovic ZB; Yong SL; Mahajan A; Wang Q; Sen S
    J Mol Biol; 2008 Jan; 375(3):637-49. PubMed ID: 18037434
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Silencing the myotrophin gene by RNA interference leads to the regression of cardiac hypertrophy.
    Gupta S; Maitra R; Young D; Gupta A; Sen S
    Am J Physiol Heart Circ Physiol; 2009 Aug; 297(2):H627-36. PubMed ID: 19502558
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activation of nuclear factor-kappaB is necessary for myotrophin-induced cardiac hypertrophy.
    Gupta S; Purcell NH; Lin A; Sen S
    J Cell Biol; 2002 Dec; 159(6):1019-28. PubMed ID: 12486112
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiac-specific blockade of NF-kappaB in cardiac pathophysiology: differences between acute and chronic stimuli in vivo.
    Brown M; McGuinness M; Wright T; Ren X; Wang Y; Boivin GP; Hahn H; Feldman AM; Jones WK
    Am J Physiol Heart Circ Physiol; 2005 Jul; 289(1):H466-76. PubMed ID: 15695559
    [TBL] [Abstract][Full Text] [Related]  

  • 9. NF-kappaB activation is required for the development of cardiac hypertrophy in vivo.
    Li Y; Ha T; Gao X; Kelley J; Williams DL; Browder IW; Kao RL; Li C
    Am J Physiol Heart Circ Physiol; 2004 Oct; 287(4):H1712-20. PubMed ID: 15142841
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Artemisinin, an anti-malarial agent, inhibits rat cardiac hypertrophy via inhibition of NF-κB signaling.
    Xiong Z; Sun G; Zhu C; Cheng B; Zhang C; Ma Y; Dong Y
    Eur J Pharmacol; 2010 Dec; 649(1-3):277-84. PubMed ID: 20863781
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of NF-kappaB induces regression of cardiac hypertrophy, independent of blood pressure control, in spontaneously hypertensive rats.
    Gupta S; Young D; Sen S
    Am J Physiol Heart Circ Physiol; 2005 Jul; 289(1):H20-9. PubMed ID: 15749748
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiac-restricted Overexpression of TRAF3 Interacting Protein 2 (TRAF3IP2) Results in Spontaneous Development of Myocardial Hypertrophy, Fibrosis, and Dysfunction.
    Yariswamy M; Yoshida T; Valente AJ; Kandikattu HK; Sakamuri SS; Siddesha JM; Sukhanov S; Saifudeen Z; Ma L; Siebenlist U; Gardner JD; Chandrasekar B
    J Biol Chem; 2016 Sep; 291(37):19425-36. PubMed ID: 27466370
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Myotrophin-kappaB DNA interaction in the initiation process of cardiac hypertrophy.
    Gupta S; Sen S
    Biochim Biophys Acta; 2002 May; 1589(3):247-60. PubMed ID: 12031792
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Blockade of NF-kappaB improves cardiac function and survival without affecting inflammation in TNF-alpha-induced cardiomyopathy.
    Kawamura N; Kubota T; Kawano S; Monden Y; Feldman AM; Tsutsui H; Takeshita A; Sunagawa K
    Cardiovasc Res; 2005 Jun; 66(3):520-9. PubMed ID: 15914117
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardiomyocyte NF-κB p65 promotes adverse remodelling, apoptosis, and endoplasmic reticulum stress in heart failure.
    Hamid T; Guo SZ; Kingery JR; Xiang X; Dawn B; Prabhu SD
    Cardiovasc Res; 2011 Jan; 89(1):129-38. PubMed ID: 20797985
    [TBL] [Abstract][Full Text] [Related]  

  • 16. NF-kappaB as an integrator of diverse signaling pathways: the heart of myocardial signaling?
    Jones WK; Brown M; Ren X; He S; McGuinness M
    Cardiovasc Toxicol; 2003; 3(3):229-54. PubMed ID: 14555789
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardiac overexpression of myotrophin triggers myocardial hypertrophy and heart failure in transgenic mice.
    Sarkar S; Leaman DW; Gupta S; Sil P; Young D; Morehead A; Mukherjee D; Ratliff N; Sun Y; Rayborn M; Hollyfield J; Sen S
    J Biol Chem; 2004 May; 279(19):20422-34. PubMed ID: 14970239
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Myocardial cell death and regeneration during progression of cardiac hypertrophy to heart failure.
    Sarkar S; Chawla-Sarkar M; Young D; Nishiyama K; Rayborn ME; Hollyfield JG; Sen S
    J Biol Chem; 2004 Dec; 279(50):52630-42. PubMed ID: 15385543
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Requirement of nuclear factor-kappaB in angiotensin II- and isoproterenol-induced cardiac hypertrophy in vivo.
    Freund C; Schmidt-Ullrich R; Baurand A; Dunger S; Schneider W; Loser P; El-Jamali A; Dietz R; Scheidereit C; Bergmann MW
    Circulation; 2005 May; 111(18):2319-25. PubMed ID: 15870116
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of nuclear factor-κB in the lungs prevents monocrotaline-induced pulmonary hypertension in mice.
    Li L; Wei C; Kim IK; Janssen-Heininger Y; Gupta S
    Hypertension; 2014 Jun; 63(6):1260-9. PubMed ID: 24614212
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.